Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

3(27%)

Results Posted

60%(3 trials)

Terminated

1(9%)

Phase Distribution

Ph phase_2

18%

Ph phase_4

27%

Ph phase_3

Ph not_applicable

18%

Ph phase_1

Ph early_phase_1

18%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Early Phase 1First-in-human

2(18.2%)

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

2(18.2%)

Phase 3Large-scale testing

1(9.1%)

Phase 4Post-market surveillance

3(27.3%)

N/ANon-phased studies

2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(5)

Terminated(1)

Other(1)

Detailed Status

Completed5

Recruiting3

Terminated1

unknown1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (18.2%)

Phase 11 (9.1%)

Phase 22 (18.2%)

Phase 31 (9.1%)

Phase 43 (27.3%)

N/A2 (18.2%)

Trials by Status

terminated19%

unknown19%

completed545%

enrolling_by_invitation19%

recruiting327%

Recent Activity

3 active trials

Showing 5 of 11

enrolling_by_invitationnot_applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

NCT07568574

completedearly_phase_1

Clinical Trials (11)

Showing 11 of 11 trials

NCT07568574Not Applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling By Invitation

NCT03973229Early Phase 1

Neuroendocrine Risk for PTSD in Women

Completed

NCT04833140Phase 3

Estrogen Administration for the Treatment of NASH in Postmenopausal Women

Recruiting

NCT06798571Phase 4

Role of Menopause in Thermoregulation

Recruiting

NCT05903820Phase 4

Rhythmic Estradiol and Bone Health

Completed

NCT03815929Phase 2

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

Completed

NCT04671966Phase 4

Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction

Recruiting

NCT04597099Early Phase 1

Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

Unknown

NCT03681691Phase 1

The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women

Completed

NCT04359329Phase 2

Estrogen Patch for COVID-19 Symptoms

Terminated

NCT02524561Not Applicable

KEEPS Mammographic Density And Breast Health Ancillary Study

Completed

All 11 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 11